Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Andexxa Lawsuit Andexxa recall lawsuits are being investigated after the FDA linked the drug to an increased risk of thrombotic events, including stroke, heart attack, pulmonary embolism, and fatal blood clots.
ByHeart Formula Recall Lawsuit Parents are now filing ByHeart recall lawsuits alleging that contaminated infant formula caused botulism and other serious illnesses after the company failed to prevent or warn about dangerous manufacturing lapses.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Glyphosate Health and Environmental Concerns Lead Mexico to Block Shipments of Weedkiller November 27, 2019 Irvin Jackson Add Your Comments Pointing to potential environmental impacts and health risks from glyphosate, the active ingredient in the weedkiller Roundup, the Medican government refused to allow a 1,000-ton shipment of the herbicide to cross it’s borders this month. On November 25, the Mexican Secretariat of Environment and Natural Resources issued a press release (in Spanish), announcing the decision to deny the import of glyphosate, and a general ban on its use. The ministry expressed concern over that glyphosate may damage to human health, the environment, and impact pollinators; such as bees, who help fertilize vital plant life. ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The decision was based on precautionary principles, meaning Bayer and its Monsanto subsidiary would have to conclusively prove that the herbicide does not affect the environment or put residents’ health at risk before glyphosate is again allowed in the country. Mexico joins Thailand, Austria and Germany in decisions to ban or phase out glyphosate use in recent years. The bans come amid concerns that Roundup exposure is linked to an increased risk of non-Hodgkins lymphoma. Roundup and its active ingredient, glyphosate, were linked to an increased risk of non-Hodgkin’s lymphoma by the World Health Organization’s International Agency for Research on Cancer (IARC) in 2015. In the United States, Bayer and its Monsanto subsidiary face about 43,000 Roundup lawsuits brought by farmers, agricultural works and consumers nationwide, each raising similar allegations that users developed non-Hodgkins lymphoma or other forms of cancer after repeated exposure to the glyphosate-based weedkiller. Three cases have gone to trial so far, each resulting in massive damage awards after a jury found that Roundup exposure caused the plaintiffs’ cancer diagnosis and that Monsanto has withheld safety information for years. While Bayer continues to maintain that glyphosate is safe, following high-profile losses in the first three cases to go to trial, where juries awarded massive damages to individuals diagnosed with cancer following exposure to glyphosate, pressure is mounting on the company to reach Roundup settlements for glyphosate cancer claims, with a number of additional cases being prepared for trial. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Bayer, Cancer, Glyphosate, Herbicide, Mexico, Monsanto, Non-Hodgkins Lymphoma, Roundup, Weed Killer More Roundup Lawsuit Stories Roundup Safety Study Retracted Decades After Publication December 8, 2025 Monsanto Roundup Settlement Avoids $2B Payout in Non-Hodgkin’s Lymphoma Lawsuit November 18, 2025 Bayer’s Roundup Lawsuit Payouts Result in Another $1.37B in Reserves August 4, 2025 0 Comments LinkedInThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (Posted: yesterday) A federal judge has scheduled the first Depo-Provera brain tumor pilot trial to begin sometime in December 2026. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (12/17/2025)Lawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)Court To Weigh Evidence That Depo-Provera Causes Meningioma Tumors in Mid-2026 (12/08/2025) Amazon Fire Pit Lawsuit Set For Trial in February 2027 (Posted: 2 days ago) A federal judge has set a February 2027 trial date for an Amazon fire pit lawsuit alleging that a teenager suffered severe burn injuries after a relative attempted to relight the device. MORE ABOUT: TABLETOP FIRE PIT LAWSUITFamily Dollar, Amazon Face Lawsuit Over Tabletop Fire Pit Burn Injuries (12/03/2025)Amazon Space Heater Lawsuit Claims Defective Device Caused First Degree Burns (11/24/2025)Amazon Tabletop Fire Pit Fuel Recall Issued Due to “Deadly Risk of Flash Fire”: CPSC (11/21/2025) Dupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (Posted: 5 days ago) An Illinois woman diagnosed with stage IV cutaneous T-cell lymphoma (CTCL) after two years of Dupixent injections has filed a lawsuit against the drug manufacturers. MORE ABOUT: DUPIXENT LAWSUITLawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025)Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (12/02/2025)
Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (Posted: yesterday) A federal judge has scheduled the first Depo-Provera brain tumor pilot trial to begin sometime in December 2026. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (12/17/2025)Lawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)Court To Weigh Evidence That Depo-Provera Causes Meningioma Tumors in Mid-2026 (12/08/2025)
Amazon Fire Pit Lawsuit Set For Trial in February 2027 (Posted: 2 days ago) A federal judge has set a February 2027 trial date for an Amazon fire pit lawsuit alleging that a teenager suffered severe burn injuries after a relative attempted to relight the device. MORE ABOUT: TABLETOP FIRE PIT LAWSUITFamily Dollar, Amazon Face Lawsuit Over Tabletop Fire Pit Burn Injuries (12/03/2025)Amazon Space Heater Lawsuit Claims Defective Device Caused First Degree Burns (11/24/2025)Amazon Tabletop Fire Pit Fuel Recall Issued Due to “Deadly Risk of Flash Fire”: CPSC (11/21/2025)
Dupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (Posted: 5 days ago) An Illinois woman diagnosed with stage IV cutaneous T-cell lymphoma (CTCL) after two years of Dupixent injections has filed a lawsuit against the drug manufacturers. MORE ABOUT: DUPIXENT LAWSUITLawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025)Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (12/02/2025)